• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 E 在非酒精性脂肪性肝病中的作用。

Role of vitamin E in nonalcoholic fatty liver disease.

机构信息

Division of Health Science, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.

出版信息

IUBMB Life. 2019 Apr;71(4):516-522. doi: 10.1002/iub.1991. Epub 2018 Dec 27.

DOI:10.1002/iub.1991
PMID:30592129
Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. NAFLD manifests as hepatic lipid accumulation, insulin resistance, and inflammation, and can progress to nonalcoholic steatohepatitis (NASH) and cirrhosis. However, the underlying mechanisms of NAFLD, including those that drive its progression, are unclear. Both liver-resident (Kupffer cells) and recruited macrophages play a crucial role in the development of insulin resistance and NASH. Therefore, NALFD could potentially be ameliorated by modifying the polarization of macrophages/Kupffer cells. Reactive oxygen species induce oxidative stress, which is implicated in the progression of NASH. Micronutrients, including vitamins, are potent antioxidants that exert anti-inflammatory effects, and are used in the treatment of NAFLD. We review here the molecular mechanisms of the pathogenesis of NAFLD and the potential utility of vitamin E in its prevention and/or treatment. © 2018 IUBMB Life, 71(4):516-522, 2019.

摘要

非酒精性脂肪性肝病 (NAFLD) 是全球最常见的慢性肝病之一。NAFLD 的表现为肝内脂质积聚、胰岛素抵抗和炎症,可进展为非酒精性脂肪性肝炎 (NASH) 和肝硬化。然而,NAFLD 的潜在机制,包括驱动其进展的机制尚不清楚。肝内固有细胞(库普弗细胞)和募集的巨噬细胞在胰岛素抵抗和 NASH 的发展中起关键作用。因此,通过改变巨噬细胞/库普弗细胞的极化,NAFLD 可能得到改善。活性氧诱导氧化应激,这与 NASH 的进展有关。微量营养素,包括维生素,是有效的抗氧化剂,具有抗炎作用,并用于治疗 NAFLD。我们在此回顾了 NAFLD 发病机制的分子机制以及维生素 E 在其预防和/或治疗中的潜在用途。©2018 IUBMB Life,71(4):516-522,2019。

相似文献

1
Role of vitamin E in nonalcoholic fatty liver disease.维生素 E 在非酒精性脂肪性肝病中的作用。
IUBMB Life. 2019 Apr;71(4):516-522. doi: 10.1002/iub.1991. Epub 2018 Dec 27.
2
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments.非酒精性脂肪性肝病与胰岛素抵抗:新见解及潜在新疗法
Nutrients. 2017 Apr 14;9(4):387. doi: 10.3390/nu9040387.
3
Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.微量营养素抗氧化剂与非酒精性脂肪性肝病
Int J Mol Sci. 2016 Aug 23;17(9):1379. doi: 10.3390/ijms17091379.
4
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的当前药物治疗方法。
World J Gastroenterol. 2015 Apr 7;21(13):3777-85. doi: 10.3748/wjg.v21.i13.3777.
5
Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis.类胡萝卜素对非酒精性脂肪性肝病的新作用:巨噬细胞极化与肝脏稳态
Nutrients. 2016 Jun 24;8(7):391. doi: 10.3390/nu8070391.
6
Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E.虾青素可预防并逆转小鼠饮食诱导的胰岛素抵抗和脂肪性肝炎:与维生素E的比较。
Sci Rep. 2015 Nov 25;5:17192. doi: 10.1038/srep17192.
7
Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)的分子机制。
Adv Exp Med Biol. 2021;1261:223-229. doi: 10.1007/978-981-15-7360-6_20.
8
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的病理生理学。
Clin Liver Dis. 2018 Feb;22(1):23-37. doi: 10.1016/j.cld.2017.08.007. Epub 2017 Oct 18.
9
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.炎症性单核细胞募集的治疗性抑制可减少脂肪性肝炎和肝纤维化。
Hepatology. 2018 Apr;67(4):1270-1283. doi: 10.1002/hep.29544. Epub 2018 Feb 19.
10
Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.补充维生素E对非酒精性脂肪性肝病、非酒精性脂肪性肝炎和慢性丙型肝炎患者转氨酶水平的影响:一项荟萃分析的结果
Nutrition. 2014 Sep;30(9):986-91. doi: 10.1016/j.nut.2014.01.016. Epub 2014 Feb 20.

引用本文的文献

1
Induction of Autophagy as a Therapeutic Breakthrough for NAFLD: Current Evidence and Perspectives.诱导自噬作为非酒精性脂肪性肝病的治疗突破:当前证据与展望
Biology (Basel). 2025 Aug 4;14(8):989. doi: 10.3390/biology14080989.
2
Potential Applications and Risks of Supranutritional Selenium Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Critical Review.超营养剂量补充硒在代谢功能障碍相关脂肪性肝病中的潜在应用与风险:一项批判性综述
Nutrients. 2025 Jul 30;17(15):2484. doi: 10.3390/nu17152484.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective.
代谢功能障碍相关脂肪性肝病:从极低密度脂蛋白角度看
Biomolecules. 2025 Jul 11;15(7):990. doi: 10.3390/biom15070990.
4
The Effects of Co-administration of Lithium and Vitamin E on Hepatic Oxidative Status in Aged Male and Female Rats: Biochemical and Histomorphological Evaluations.锂与维生素E联合给药对老年雄性和雌性大鼠肝脏氧化状态的影响:生化与组织形态学评估
Biol Trace Elem Res. 2025 Jun 26. doi: 10.1007/s12011-025-04722-x.
5
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.水飞蓟素用于患有代谢功能障碍相关脂肪性肝病的成年人。
Cochrane Database Syst Rev. 2025 Jun 24;6(6):CD015524. doi: 10.1002/14651858.CD015524.pub2.
6
From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood.从儿童肥胖到儿童期氧化应激导致的代谢功能障碍相关脂肪性肝病(MASLD)和高脂血症。
Metabolites. 2025 Apr 24;15(5):287. doi: 10.3390/metabo15050287.
7
Targeting Metabolism: Innovative Therapies for MASLD Unveiled.靶向代谢:非酒精性脂肪性肝炎的创新疗法揭秘。
Int J Mol Sci. 2025 Apr 25;26(9):4077. doi: 10.3390/ijms26094077.
8
Association of Composite Dietary Antioxidant Index With the Risk of Nonalcoholic Fatty Liver Disease and All-Cause and Cause-Specific Mortality: Evidence From NHANES 2001-2018.复合膳食抗氧化指数与非酒精性脂肪性肝病风险以及全因死亡率和特定病因死亡率的关联:来自2001 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Int J Endocrinol. 2025 Apr 18;2025:3255533. doi: 10.1155/ije/3255533. eCollection 2025.
9
Combination therapy with vitamin E and ertugliflozin in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a randomized clinical trial.维生素E与依鲁格列净联合治疗非酒精性脂肪性肝病合并2型糖尿病患者:一项随机临床试验。
Ir J Med Sci. 2025 Apr 9. doi: 10.1007/s11845-025-03945-0.
10
Association between the composite dietary antioxidant index and non-alcoholic fatty liver disease: evidence from National Health and Nutrition Examination Survey 2005-2016.复合膳食抗氧化指数与非酒精性脂肪性肝病之间的关联:来自2005 - 2016年美国国家健康与营养检查调查的证据
Front Nutr. 2025 Jan 23;12:1473487. doi: 10.3389/fnut.2025.1473487. eCollection 2025.